trial
as of 2026-07-01Comparison of Aripiprazole Versus Higher Metabolic Risk Antipsychotic Drugs on Adiposity Using MRI
NCTId NCT01739127
at a glance
Phase — · Completed
Enrollment 83 (actual)
Sponsored by University of British Columbia
Primary completion 2016-02
Synthesized from structured facts only — each point cited above.
Design & status
Phase
—
Status
Completed
Enrollment
83 (actual)
Study type
Observational
Allocation
—
Model
—
Masking
—
Start
2012-11
Primary completion
2016-02
Eligibility
ALL · 12 Years
Interventions & indications
Sponsors
University of British ColumbiaLead Sponsor
Bristol-MyersCollaborator
Investigators
1
Alasdair M Barr, Ph.D.Principal Investigator
Sites
1 total
Vancouver, Canada
Facts & assertions
4 sourced
Enrollment
83
Phase
NA
Primary Completion Date
2016-02
Status
COMPLETED
relationships
The graph out of here
drug
drug
drug
lead_sponsor
collaborator
company
indication
investigator
person